The Indian government has introduced a suite of new policies to boost joint ventures (JVs) in the healthcare sector, aiming to expand infrastructure, promote technology infusion, and improve access to quality medical services across the country. Spearheaded by the Ministry of Health and Family Welfare, in coordination with NITI Aayog and state health departments, these policies encourage collaboration between domestic healthcare providers, global medical technology firms, hospital chains, and pharmaceutical manufacturers to address gaps in healthcare delivery, especially in underserved regions.

Under the updated framework, JVs are now eligible for priority status in government-supported initiatives such as Ayushman Bharat Health Infrastructure Mission, PM-Ayushman Bharat Digital Mission, and Medical Devices Parks. The government is offering land at subsidized rates, faster clearances, custom duty exemptions for imported equipment, and production-linked incentives (PLI) for JVs involved in the local manufacturing of medical devices, diagnostic equipment, and essential drugs. Additionally, 100% FDI is permitted under the automatic route in hospitals, diagnostics, and medical device manufacturing, making it easier for foreign healthcare entities to partner with Indian firms.

Special incentives are provided for joint ventures that focus on telemedicine, digital health platforms, clinical research, and capacity building through medical education. Emphasis is also placed on JVs that contribute to affordable healthcare models, especially in Tier 2 and Tier 3 cities. These policies aim to create a robust, self-reliant healthcare ecosystem in India, improve public-private collaboration, and transform India into a regional hub for medical innovation and patient care. Through these supportive measures, the government envisions scaling up healthcare services, enhancing accessibility, and building long-term resilience in the sector.